AACE ePoster Library

CANAGLIFLOZIN PROVIDES GREATER IMPROVEMENT IN RISK FACTORS ASSOCIATED WITH METABOLIC SYNDROME VERSUS GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME ON BACKGROUND METFORMIN
AACE ePoster Library. MERTON K. 05/27/16; 131402; 306
KATHERINE MERTON
KATHERINE MERTON
Login now to access Regular content available to all registered users.
Rate & Comment (0)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies